CA2667476A1 - Carte genetique des genes humains associes a l'asthme - Google Patents

Carte genetique des genes humains associes a l'asthme Download PDF

Info

Publication number
CA2667476A1
CA2667476A1 CA002667476A CA2667476A CA2667476A1 CA 2667476 A1 CA2667476 A1 CA 2667476A1 CA 002667476 A CA002667476 A CA 002667476A CA 2667476 A CA2667476 A CA 2667476A CA 2667476 A1 CA2667476 A1 CA 2667476A1
Authority
CA
Canada
Prior art keywords
gene
cell
tables
asthma disease
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002667476A
Other languages
English (en)
Inventor
Rene Allard
Abdelmajid Belouchi
Walter Edward Bradley
Pascal Croteau
Sophie Debrus
Helene Fournier
Tim Keith
Randall David Little
Quynh Nguyen-Huu
Bruno Paquin
John Verner Raelson
Jonathan Segal
Paul Van Eerdewegh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genizon Biosciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2667476A1 publication Critical patent/CA2667476A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Ecology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002667476A 2006-11-02 2007-11-02 Carte genetique des genes humains associes a l'asthme Abandoned CA2667476A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85600306P 2006-11-02 2006-11-02
US60/856,003 2006-11-02
PCT/US2007/083522 WO2008085601A2 (fr) 2006-11-02 2007-11-02 Carte génétique des gènes humains associés à l'asthme

Publications (1)

Publication Number Publication Date
CA2667476A1 true CA2667476A1 (fr) 2008-07-17

Family

ID=39609231

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002667476A Abandoned CA2667476A1 (fr) 2006-11-02 2007-11-02 Carte genetique des genes humains associes a l'asthme

Country Status (3)

Country Link
EP (1) EP2082343A2 (fr)
CA (1) CA2667476A1 (fr)
WO (1) WO2008085601A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221066A1 (fr) * 2009-02-18 2010-08-25 Sanofi-Aventis Utilisation de modulateur d'activité de VgII3 pour la modulation d'adipogenèse
AU2010267835C1 (en) * 2009-07-03 2015-02-26 University College Cardiff Consultants Limited Diagnosis and treatment of Alzheimer's disease
US9872857B2 (en) 2009-10-23 2018-01-23 The Translational Genomics Research Institutet Methods of using propentofylline to treat glioma and glioblastoma
WO2011050350A1 (fr) * 2009-10-23 2011-04-28 The Translational Genomics Research Institute Méthodes et kits utilisés dans l'identification d'un glioblastome
EP2577316B1 (fr) * 2010-05-31 2017-02-08 University Hospital of Basel Méthode pour tester une infection ou une inflammation des voies respiratoires inférieures
SI2612152T1 (sl) * 2010-08-31 2020-10-30 Otto-Von-Guericke-Universitaet Magdeburg Postopek za diagnozo infektivnega peritonitisa in napoved resnosti in izida le-tega pri ljudeh
DK178879B1 (en) * 2012-05-26 2017-04-24 Hans Bisgaard Method of diagnosing asthma and other wheezing disorders.
WO2014139182A1 (fr) 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions et méthodes d'utilisation de peptides de néogenèse d'îlots et d'analogues de ceux-ci
WO2018087285A1 (fr) * 2016-11-10 2018-05-17 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Protéines de liaison à l'antigène or10h1 et leurs utilisations
EP3321280B8 (fr) * 2016-11-10 2021-03-10 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulateurs immunitaires de réduction d'immuno-résistance dans un mélanome et d'autres maladies proliferatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions

Also Published As

Publication number Publication date
WO2008085601A2 (fr) 2008-07-17
EP2082343A2 (fr) 2009-07-29
WO2008085601A3 (fr) 2008-12-11

Similar Documents

Publication Publication Date Title
US20090305900A1 (en) Genemap of the human genes associated with longevity
WO2008024114A1 (fr) Carte génétique des gènes humains associés a la schizophrénie
CA2667476A1 (fr) Carte genetique des genes humains associes a l'asthme
US20100120627A1 (en) Genemap of the human genes associated with psoriasis
US20100144538A1 (en) Genemap of the human genes associated with schizophrenia
US20100291551A1 (en) Genemap of the human associated with crohn's disease
US20100120628A1 (en) Genemap of the human genes associated with adhd
JP6496003B2 (ja) Ｆｇｆ−１８化合物に対する応答性を予測するための遺伝子マーカー
CA2620082A1 (fr) Carte genetique de genes humains associes a la maladie de crohn
US20100099083A1 (en) Crohn disease susceptibility gene
WO2009026116A2 (fr) Cartographie génétique des gènes humains associés à la longévité
US10519501B2 (en) Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same
WO2009039244A2 (fr) Carte génique des gènes humains associés à la maladie de crohn
US20100099087A1 (en) Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease
WO2008123901A2 (fr) Carte génétique des gènes humains associés à l'endométriose
US20160076104A1 (en) Methods and compositions for assessment of pulmonary function and disorders
US20130281319A1 (en) Methods and compositions for assessment of pulmonary function and disorders
WO2008055196A2 (fr) Carte génétique des gènes humains associés à la calvitie masculine
KR101617612B1 (ko) 한국인의 고혈압 예측용 ｓｎｐ 마커
KR20150092937A (ko) 한국인의 고혈압 예측용 ｓｎｐ 마커

Legal Events

Date Code Title Description
FZDE Discontinued